In this issue:
Higher SAE risk in psoriasis patients ineligible for RCTs
Summary of the evidence for psoriasis combination therapies
Higher CVD risk in women with psoriasis
Ustekinumab: sustained efficacy in psoriasis
Adalimumab: long-term efficacy and safety
Vitamin D supplementation for psoriasis?
PUVA: dose-dependent risk of squamous cell cancer
Which assessment tool for psoriasis?
Self-medication and treatment adherence in psoriasis
Recommendations on topical treatment and phototherapy
Please login below to download this issue (PDF)